Mass General Brigham: Preliminary Clinical Trial Results Show 'Dramatic and Rapid' Regression of Glioblastoma After Next Generation CAR-T Therapy
March 14, 2024
March 14, 2024
BOSTON, Massachusetts, March 14 -- Mass General Brigham issued the following news release:
* * *
Mass General Cancer Center researchers took a new approach to CAR-T, engineering CAR-TEAM cells to treat mixed cell populations within tumors
Working in collaboration with Mass General neurosurgeons, the team tested the approach in a phase 1 clinical trial of patients with recurrent glioblastoma
First three patients in the trial showed dramatic resp . . .
* * *
Mass General Cancer Center researchers took a new approach to CAR-T, engineering CAR-TEAM cells to treat mixed cell populations within tumors
Working in collaboration with Mass General neurosurgeons, the team tested the approach in a phase 1 clinical trial of patients with recurrent glioblastoma
First three patients in the trial showed dramatic resp . . .